1.
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
by Gueler, Aysel
AIDS (London), 2017, Vol.31 (3), p.427-436
2.
PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
by Banga, Riddhima
Nature medicine, 2016, Vol.22 (7), p.754-761
3.
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
by Helleberg, Marie
AIDS (London), 2015, Vol.29 (2), p.221-229
4.
Dominant TNF-α + Mycobacterium tuberculosis -specific CD4 + T cell responses discriminate between latent infection and active disease
by Pantaleo, Giuseppe
Nature medicine, 2011, Vol.17 (3), p.372-376
5.
An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring
by Krummenacher, Isabelle
AIDS care, 2011, Vol.23 (5), p.550-561
6.
High prevalence of physical inactivity among patients from the Swiss HIV Cohort Study
by Schäfer, Juliane
AIDS care, 2017, Vol.29 (8), p.1056-1061
7.
Suboptimal access to primary healthcare among street-based sex workers in southwest Switzerland
by Darling, Katharine Elizabeth Anna
Postgraduate medical journal, 2013, Vol.89 (1053), p.371-375
8.
Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study: Latent Class Analysis
by Keiser, Olivia
AIDS and behavior, 2011, Vol.16 (2), p.245-255
9.
A cross-sectional survey of attitudes to HIV risk and rapid HIV testing among clients of sex workers in Switzerland
by Darling, Katharine E A
Sexually transmitted infections, 2012, Vol.88 (6), p.462-464
10.
Severe atherosclerotic aortoiliac occlusive disease in a young HIV-infected patient
by Periard, Daniel, Dr
The Lancet infectious diseases, 2008, Vol.8 (9), p.582-582
11.
Outcomes of Patients on Dual-Boosted PI Regimens: Experience of the Swiss HIV Cohort Study
by Osih, Regina B.
AIDS research and human retroviruses, 2010, Vol.26 (11), p.1239-1246
12.
The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV
by Kohler, Philipp
AIDS (London), 2015, Vol.29 (18), p.2509-2515
13.
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
by SIMIONI, Samanta
AIDS (London), 2010, Vol.24 (9), p.1243-1250
14.
Determinants of HIV-1 broadly neutralizing antibody induction
by Rusert, Peter
Nature medicine, 2016, Vol.22 (11), p.1260-1267
15.
Non-targeted HIV testing in the emergency department: not just how but where
by Tan, Rainer
Expert review of anti-infective therapy, 2018, Vol.16 (12), p.893-905
16.
HIV-associated neurocognitive disorders: a changing pattern
by Simioni, Samanta
Future Neurology, 2011, Vol.6 (1), p.81-95
17.
Adverse events of raltegravir and dolutegravir
by Elzi, Luigia
AIDS (London), 2017, Vol.31 (13), p.1853-1858
18.
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland
by Gueler, Aysel
AIDS (London), 2015, Vol.29 (2), p.231-238
19.
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir
by GUTMANN, Christine
AIDS (London), 2010, Vol.24 (15), p.2347-2354
20.
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio
by Hughes, Rachael A
AIDS (London), 2018, Vol.32 (10), p.1361-1367
